Search
ARS Pharmaceuticals Inc
SPRYAdd to Watchlist
8.560USD
+0.620+7.81%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
850.01MMarket Cap
LossP/E TTM
ARS Pharmaceuticals Inc Earnings Date
Period
FY2025 Earnings Date
Revenue(YoY)
84.28M
-5.46%
EPS(YoY)
-1.74
-2206.28%
Analyst Rating
STRONG BUY
2026-07-02
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of ARS Pharmaceuticals Inc?
According to ARS Pharmaceuticals Inc's FY2025 earnings report, its total revenue reached 84.28M, with a year-on-year change of -5.46.
What are the current assets of ARS Pharmaceuticals Inc?
According to ARS Pharmaceuticals Inc's FY2025 earnings report, its current assets were 284.90M, with a year-on-year change of -14.78.
What are the total assets of ARS Pharmaceuticals Inc?
According to ARS Pharmaceuticals Inc's FY2025 earnings report, its total assets of ARS Pharmaceuticals Inc were 327.65M, with a year-on-year change of -6.69.
What are the total liabilities of ARS Pharmaceuticals Inc?
According to ARS Pharmaceuticals Inc's FY2025 earnings report, its total liabilities of ARS Pharmaceuticals Inc were 213.39M, with a year-on-year change of 126.16.
What is the total equity of ARS Pharmaceuticals Inc?
According to ARS Pharmaceuticals Inc's FY2025 earnings report, its total equity of ARS Pharmaceuticals Inc was 114.26M, with a year-on-year change of -55.51.
What is the net investment of ARS Pharmaceuticals Inc?
According to ARS Pharmaceuticals Inc's FY2025 earnings report, its net investment of ARS Pharmaceuticals Inc was 56.77M, with a year-on-year change of 153.50.
What is the net financing of ARS Pharmaceuticals Inc?
According to ARS Pharmaceuticals Inc's FY2025 earnings report, its net financing of ARS Pharmaceuticals Inc was 104.60M, with a year-on-year change of 44.47.
What is the Earnings Per Share (EPS) of ARS Pharmaceuticals Inc?
According to ARS Pharmaceuticals Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -1.74, with a year-on-year change of -2206.28.
What is the net margin of ARS Pharmaceuticals Inc?
According to ARS Pharmaceuticals Inc's FY2025 earnings report, its net profit margin was -203.25, with a year-on-year change of -2365.55.
What is the gross margin of ARS Pharmaceuticals Inc?
According to ARS Pharmaceuticals Inc's FY2025 earnings report, its gross margin was 75.77, with a year-on-year change of -23.39.
What is the Return on Equity (ROE) of ARS Pharmaceuticals Inc?
According to ARS Pharmaceuticals Inc's FY2025 earnings report, its Return on Equity (ROE) was -92.33, with a year-on-year change of -2914.22.
What is the Return on Assets (ROA) of ARS Pharmaceuticals Inc?
According to ARS Pharmaceuticals Inc's FY2025 earnings report, its Return on Assets (ROA) was -50.47, with a year-on-year change of -1943.71.
What is the operating profit of ARS Pharmaceuticals Inc?
According to ARS Pharmaceuticals Inc's FY2025 earnings report, its operating profit was -179.45M, with a year-on-year change of -5720.56.